本研究旨在探讨可能影响前列腺癌患者选择雄激素剥夺治疗的因素。这是一项在香港威尔斯亲王医院进行的横断面研究。本研究将招募一百名患者。
适应症：Prostate Cancer
入组条件
纳入标准
- Prostate cancer only happens in male patients
- Patients who are currently receiving at least one dose of LHRH agonist or antagonist, as androgen deprivation therapy
- Patients who are willing to consent and participate in this study
排除标准
- Patients who received bilateral orchidectomy as androgen deprivation therapy
- Patients who, in the opinion of investigators, are not able to comprehend about the study questions
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年11月5日。